Flazoparib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Flazoparib, covering 2025-07-02 to 2025-07-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of Flazoparib Combined With Temozolomide After the Completion of Standard Concurrent Chemoradiotherapy (CCRT) in Newly Diagnosed Glioblastoma [Phase 2]